A randomized crossover study comparing tafluprost 0.005% with travoprost 0.004% in patients with normal-tension glaucoma
Takanori Mizoguchi,1 Mineo Ozaki,2 Kazuhiko Unoki,3 Yoshinori Dake,4 Takahiko Eto,5 Miki Arai61Mizoguchi Eye Clinic, 2Ozaki Eye Clinic, Miyazaki, Japan; 3Unoki Eye Clinic, Kagoshima, Japan; 4Dake Eye Clinic, Nagasaki, Japan; 5Eto Eye Clinic, Oita, Japan; 6Arai Eye Clinic, Fukuoka, JapanPurpose: We c...
Guardado en:
Autores principales: | Mizoguchi T, Ozaki M, Unoki K, Dake Y, Eto T, Arai M |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7a83617bd98544128a10758012128c47 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Efficacy, safety, and tolerability of travoprost 0.004% BAK-free versus prior treatment with latanoprost 0.005% in Japanese patients
por: Michael J Miyashiro, et al.
Publicado: (2010) -
A comfort comparison of travoprost BAK-free 0.004% versus latanoprost 0.005% in patients with primary open-angle glaucoma or ocular hypertension
por: David A Godfrey, et al.
Publicado: (2009) -
A study of the safety and efficacy of travoprost 0.004%/timolol 0.5% ophthalmic solution compared to latanoprost 0.005% and timolol 0.5% dosed concomitantly in patients with open-angle glaucoma or ocular hypertension
por: Douglas J Rhee, et al.
Publicado: (2008) -
First experience with BAK-free travoprost 0.004% in topical glaucoma medication
por: Gado AS, et al.
Publicado: (2011) -
Efficacy of the travoprost/timolol fixed combination versus the concomitant use of travoprost 0.004% and timolol 0.1% gel formulation
por: Kozobolis V, et al.
Publicado: (2018)